Bryan W. King

3.2k total citations
17 papers, 993 citations indexed

About

Bryan W. King is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Bryan W. King has authored 17 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Bryan W. King's work include Synthetic Organic Chemistry Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Bryan W. King is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Bryan W. King collaborates with scholars based in United States, Germany and India. Bryan W. King's co-authors include Michael T. Crimmins, Elie A. Tabet, Kleem Chaudhary, William J. Zuercher, Allison L. Choy, James J.‐W. Duan, John L. Gilmore, Rui‐Qin Liu, Maryanne Covington and Carl P. Decicco and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and The Journal of Organic Chemistry.

In The Last Decade

Bryan W. King

17 papers receiving 964 citations

Peers

Bryan W. King
Paul M. Scola United States
Wensheng Yu United States
Michael C. Matelich United States
D. Askin United States
A. Jonathan Singh New Zealand
Paul M. Scola United States
Bryan W. King
Citations per year, relative to Bryan W. King Bryan W. King (= 1×) peers Paul M. Scola

Countries citing papers authored by Bryan W. King

Since Specialization
Citations

This map shows the geographic impact of Bryan W. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan W. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan W. King more than expected).

Fields of papers citing papers by Bryan W. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan W. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan W. King. The network helps show where Bryan W. King may publish in the future.

Co-authorship network of co-authors of Bryan W. King

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan W. King. A scholar is included among the top collaborators of Bryan W. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan W. King. Bryan W. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Horton, J.R., Kristen Wong, Ren Ren, et al.. (2022). Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors. Structure. 30(6). 793–802.e5. 19 indexed citations
2.
Horton, J.R., Kristen Wong, Ren Ren, et al.. (2022). Structural Characterization of Dicyanopyridine Containing DNMT1-Selective, Non-Nucleoside Inhibitors. SSRN Electronic Journal. 1 indexed citations
3.
Xia, Bing, G. Joseph Franklin, Xiaojie Lu, et al.. (2021). DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry. ACS Medicinal Chemistry Letters. 12(7). 1166–1172. 21 indexed citations
4.
Charnley, Adam K., M.A. Convery, Emma J. Jones, et al.. (2015). Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. Bioorganic & Medicinal Chemistry. 23(21). 7000–7006. 24 indexed citations
5.
Totoritis, Rachel D., Chaya Duraiswami, Amy Taylor, et al.. (2011). Understanding the Origins of Time-Dependent Inhibition by Polypeptide Deformylase Inhibitors. Biochemistry. 50(31). 6642–6654. 3 indexed citations
6.
Gilmore, John L., Bryan W. King, Naoyuki Asakawa, et al.. (2007). Synthesis and structure–activity relationship of a novel, non-hydroxamate series of TNF-α converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4678–4682. 20 indexed citations
7.
Gilmore, John L., Bryan W. King, Thomas Maduskuie, et al.. (2006). Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(10). 2699–2704. 38 indexed citations
8.
Cherney, Robert J., Bryan W. King, John L. Gilmore, et al.. (2006). Conversion of Potent MMP Inhibitors into Selective TACE Inhibitors.. ChemInform. 37(20). 3 indexed citations
9.
Cherney, Robert J., Bryan W. King, John L. Gilmore, et al.. (2005). Conversion of potent MMP inhibitors into selective TACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(4). 1028–1031. 22 indexed citations
10.
DeShong, Philip, et al.. (2001). Regioselectivity in the Palladium-Catalyzed Addition of Carbon Nucleophiles to Carbocyclic Derivatives. The Journal of Organic Chemistry. 67(2). 327–335. 21 indexed citations
11.
Crimmins, Michael T., Bryan W. King, Elie A. Tabet, & Kleem Chaudhary. (2001). Asymmetric Aldol Additions:  Use of Titanium Tetrachloride and (−)-Sparteine for the Soft Enolization of N-Acyl Oxazolidinones, Oxazolidinethiones, and Thiazolidinethiones. The Journal of Organic Chemistry. 66(3). 894–902. 317 indexed citations
12.
Crimmins, Michael T., et al.. (2000). Synthesis of the C1−C13 Fragment of Leucascandrolide A. Organic Letters. 2(5). 597–599. 27 indexed citations
13.
Crimmins, Michael T., Bryan W. King, William J. Zuercher, & Allison L. Choy. (2000). An Efficient, General Asymmetric Synthesis of Carbocyclic Nucleosides:  Application of an Asymmetric Aldol/Ring-Closing Metathesis Strategy. The Journal of Organic Chemistry. 65(25). 8499–8509. 84 indexed citations
14.
Crimmins, Michael T. & Bryan W. King. (1998). Asymmetric Total Synthesis of Callystatin A:  Asymmetric Aldol Additions with Titanium Enolates of Acyloxazolidinethiones. Journal of the American Chemical Society. 120(35). 9084–9085. 91 indexed citations
15.
Crimmins, Michael T., Bryan W. King, & Elie A. Tabet. (1997). Asymmetric Aldol Additions with Titanium Enolates of Acyloxazolidinethiones:  Dependence of Selectivity on Amine Base and Lewis Acid Stoichiometry. Journal of the American Chemical Society. 119(33). 7883–7884. 176 indexed citations
17.
Crimmins, Michael T. & Bryan W. King. (1996). An Efficient Asymmetric Approach to Carbocyclic Nucleosides:  Asymmetric Synthesis of 1592U89, a Potent Inhibitor of HIV Reverse Transcriptase. The Journal of Organic Chemistry. 61(13). 4192–4193. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026